{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:07:11Z","timestamp":1792440431758,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["RF-2016-02361720"],"award-info":[{"award-number":["RF-2016-02361720"]}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.kint.2020.05.013","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T10:17:28Z","timestamp":1590315448000},"page":"314-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":298,"title":["The case of complement activation in COVID-19 multiorgan impact"],"prefix":"10.1016","volume":"98","author":[{"given":"Marina","family":"Noris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.05.013_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.368.6489.356","article-title":"A rampage through the body","volume":"368","author":"Wadman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.kint.2020.05.013_bib2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(20)30627-9","article-title":"COVID-19 and Italy: what next?","volume":"395","author":"Remuzzi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2020.05.013_bib3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.05.013_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2020.05.013_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.05.013_bib6","doi-asserted-by":"crossref","unstructured":"Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv. Available at: https:\/\/doi.org\/10.1101\/2020.03.04.20031120. Accessed June 17, 2020.","DOI":"10.1038\/s41467-021-22781-1"},{"key":"10.1016\/j.kint.2020.05.013_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.05.013_bib8","doi-asserted-by":"crossref","unstructured":"Farkash EA, Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with SARS-CoV-2 [e-pub ahead of print]. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2020040432. Accessed May 5, 2020.","DOI":"10.1681\/ASN.2020040432"},{"key":"10.1016\/j.kint.2020.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.1159\/000508430","article-title":"COVID-19 attacks the kidney. Ultrastructural evidence for the presence of virus in the glomerular epithelium","author":"Abbate","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2020.05.013_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MNH.0000000000000378","article-title":"Angiotensin-converting enzyme 2 and renal disease","volume":"27","author":"Williams","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2020.05.013_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41581-020-0284-7","article-title":"Kidney involvement in COVID-19 and rationale for extracorporeal therapies","volume":"16","author":"Ronco","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.05.013_bib12","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2020.05.013_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2020.05.013_bib14","doi-asserted-by":"crossref","unstructured":"Gao T, Hu M, Zhang X, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement overactivation. medRxiv. Available at: https:\/\/doi.org\/10.1101\/2020.03.29.20041962. Accessed June 17, 2020.","DOI":"10.1101\/2020.03.29.20041962"},{"key":"10.1016\/j.kint.2020.05.013_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017377","article-title":"A\u00a0protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection","volume":"6","author":"O'Brien","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2020.05.013_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.kint.2020.05.013_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2020.05.013_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis","volume":"141","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2020.05.013_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.kint.2020.05.013_bib20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/429631","article-title":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection","volume":"191","author":"Ip","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.kint.2020.05.013_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/infdis\/jir691","article-title":"Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection","volume":"205","author":"Ling","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.kint.2020.05.013_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.kint.2020.05.013_bib23","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20052388","article-title":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways","volume":"203","author":"Mehlhop","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2020.05.013_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20407","article-title":"Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection","volume":"77","author":"Yang","year":"2005","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.kint.2020.05.013_bib25","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/emi.2015.28","article-title":"The role of C5a in acute lung injury induced by highly pathogenic viral infections","volume":"4","author":"Wang","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.kint.2020.05.013_bib26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4049\/jimmunol.166.2.1193","article-title":"Role of C5a in multiorgan failure during sepsis","volume":"166","author":"Huber-Lang","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.05.013_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.imbio.2004.09.004","article-title":"Inhibition of C5 or absence of C6 protects from sepsis mortality","volume":"209","author":"Buras","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2020.05.013_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064443","article-title":"Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury","volume":"8","author":"Garcia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2020.05.013_bib29","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.05.013_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.kint.2020.05.013_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1348-0421.2011.00309.x","article-title":"Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza","volume":"55","author":"Ohta","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.kint.2020.05.013_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI114499","article-title":"Dependence on O2-generation by xanthine oxidase of pathogenesis of influenza virus infection in mice","volume":"85","author":"Akaike","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2020.05.013_bib33","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5-C5a receptor axis","volume":"48","author":"Woodruff","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2020.05.013_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0046-8177(03)00367-8","article-title":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore","volume":"34","author":"Franks","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2020.05.013_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","article-title":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection","volume":"49","author":"Sun","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.kint.2020.05.013_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/v11010039","article-title":"Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-transgenic mice infected with MERS-CoV","volume":"11","author":"Jiang","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.kint.2020.05.013_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cid\/ciu887","article-title":"Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2020.05.013_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2020.05.013_bib39","unstructured":"Lee AYY, Connors JM, Baumann Kreuziger L, et\u00a0al. Online COVID-19 resources of the American Society of Hematology. Available at: https:\/\/www.hematology.org\/covid-19\/covid-19-and-coagulopathy. Accessed June 17, 2020."},{"key":"10.1016\/j.kint.2020.05.013_bib40","author":"Cao"},{"key":"10.1016\/j.kint.2020.05.013_bib41","doi-asserted-by":"crossref","unstructured":"Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy. medRxiv. Available at: https:\/\/doi.org\/10.1101\/2020.04.19.20054262. Accessed June 17, 2020.","DOI":"10.1101\/2020.04.19.20054262"},{"key":"10.1016\/j.kint.2020.05.013_bib42","first-page":"411","article-title":"A pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.kint.2020.05.013_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res."},{"key":"10.1016\/j.kint.2020.05.013_bib44","first-page":"195","article-title":"Study on etiology and pathology of severe acute respiratory syndrome","volume":"32","author":"Ding","year":"2003","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.kint.2020.05.013_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","article-title":"COVID-19 and Kawasaki disease: novel virus and novel case","volume":"10","author":"Jones","year":"2020","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.kint.2020.05.013_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jmv.23354","article-title":"Review: viral infections and mechanisms of thrombosis and bleeding","volume":"84","author":"Goeijenbier","year":"2012","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.kint.2020.05.013_bib47","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity\u2014a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2020.05.013_bib48","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2020.05.013_bib49","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2020.05.013_bib50","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2020.05.013_bib52","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.kint.2020.05.013_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0161-5890(99)00109-1","article-title":"Expression of the anaphylatoxin C5a\u00a0receptor in non-myeloid cells","volume":"36","author":"Zwirner","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2020.05.013_bib54","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2020.05.013_bib55","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2020.05.013_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1022362413939","article-title":"Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor","volume":"22","author":"Kilgore","year":"1998","journal-title":"Inflammation"},{"key":"10.1016\/j.kint.2020.05.013_bib57","doi-asserted-by":"crossref","first-page":"18205","DOI":"10.1016\/S0021-9258(19)81346-7","article-title":"Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity","volume":"263","author":"Sims","year":"1988","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2020.05.013_bib58","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2020.05.013_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2018.11.012","article-title":"An ex\u00a0vivo test of complement activation on endothelium for individualized eculizumab therapy in hemolytic uremic syndrome","volume":"74","author":"Galbusera","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.05.013_bib60","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4049\/jimmunol.1601121","article-title":"Interaction between multimeric von Willebrand factor and complement: a fresh look to the pathophysiology of microvascular thrombosis","volume":"199","author":"Bettoni","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.05.013_bib61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40262-019-00742-8","article-title":"Pharmacology, pharmacokinetics and pharmacodynamics of eculizumab, and possibilities for an individualized approach to eculizumab","volume":"58","author":"Wijnsma","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.kint.2020.05.013_bib62","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.05.013_bib63","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.05.013_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2011.04562.x","article-title":"Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"10","author":"Van Bijnen","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2020.05.013_bib65","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1080\/14656566.2019.1682548","article-title":"Current pharmacotherapeutic options for myasthenia gravis","volume":"20","author":"Barnett","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.kint.2020.05.013_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semnephrol.2013.08.005","article-title":"The role of the complement system in acute kidney injury","volume":"33","author":"McCullough","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2020.05.013_bib67","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/0886022X.2019.1677248","article-title":"Effect of anti-C5 antibody on recuperation from ischemia\/reperfusion-induced acute kidney injury","volume":"41","author":"Zilberman-Itskovich","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2020.05.013_bib68","unstructured":"Eculizumab (Soliris) in covid-19 infected patients (SOLID-C19). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04288713. Published February 28, 2020. Updated March 30, 2020. Accessed June 17, 2020."},{"key":"10.1016\/j.kint.2020.05.013_bib69","unstructured":"Trial evaluating efficacy and safety of eculizumab (Soliris) in patients with COVID-19 infection, nested in the CORIMUNO-19 cohort (CORIMUNO19-ECU). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04346797. Published April 15, 2020. Updated April 27, 2020. Accessed June 17, 2020."},{"key":"10.1016\/j.kint.2020.05.013_bib70","unstructured":"SOLIRIS (Eculizumab) treatment of participants with COVID-19. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04355494. Published April 21, 2020. Accessed June 17, 2020."},{"key":"10.1016\/j.kint.2020.05.013_bib71","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.kint.2020.05.013_bib72","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.05.013_bib73","unstructured":"Avdoralimab an anti-C5aR antibody, in patients with COVID-19 severe pneumonia (FORCE). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04371367. Published May 1, 2020. Accessed June 17, 2020."}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820305561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820305561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:57:14Z","timestamp":1758761834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820305561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0085253820305561"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.05.013","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case of complement activation in COVID-19 multiorgan impact","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}